The Science Says...
-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess…
-
What Is Type 5 Diabetes? Exploring the Newest Diagnostic Category
If you’ve seen a new diabetes diagnosis category circulating in medical circles and found yourself confused, thinking, “I don’t remember learning about that type in medical, nursing, or dietetics school,” don’t worry. It’s…
-
Double Diabetes: Supporting Patients Through the Diagnostic Overlap
If you’ve never heard the term “double diabetes” before, don’t be alarmed. It’s not an official diagnosis, and you likely won’t find it in a medical textbook. However, it’s a term that’s gaining…
-
Fatty Liver on the Rise: What You Need to Know
A recent study published in the Journal of the American Medical Association estimates that over 40% of the U.S. population will develop metabolic dysfunction–associated steatotic liver disease (MASLD), commonly known as fatty liver,…
-
Do Food Warning Labels Really Work?
On a recent trip abroad, I couldn’t help but notice the abundance of food warning labels on items at the local mini-mart. Bold, bright labels reading “Danger: High Fat” or “Excess Sugar” were…
